Meningococcal Conjugate Vaccine Medication Information

Learn everything you need to know about Meningococcal Conjugate Vaccine-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it.

Get up-to-date information on side effects, precautions, warnings, and proper storage to ensure safe usage.

Explore Meningococcal Conjugate Vaccine brand names commonly used in India and internationally, along with detailed pricing information. Consult your healthcare provider for tailored medical advice.

Generic Name : Meningococcal Conjugate Vaccine

Pronunciation : me NIN je KOK al KON je gate vax EEN

ICD Code : Y58.9 Therapeutic Classification : Immunizing Agents

Brand Names or Trade Names of Meningococcal Conjugate Vaccine

International :

Menactra, Menveo

Why is Meningococcal Conjugate Vaccine Prescribed? (Indications)

This medication is a vaccine, prescribed for bacterial infections (Neisseria meningitidis).

When should Meningococcal Conjugate Vaccine not be taken? (Contraindications)

Contraindicated in patients with nervous system problem (Guillain-Barr syndrome), and hypersensitivity.

What is the dosage of Meningococcal Conjugate Vaccine?

IM- Child: 2-10 months: 2 doses, 2 months apart. Additional booster dose at 12-15 months old but must be at least 2 months from the previous dose. 11-14 months: 2 doses, 2 months apart. 15-71 months: Single dose.

How should Meningococcal Conjugate Vaccine be taken?

It comes as a solution for injection to be administered by a healthcare provider into the large muscle.

What are the warnings and precautions for Meningococcal Conjugate Vaccine?

• Caution should be exercised in patients with history of poor immunity, undergoing chemotherapy, radiation therapy, any allergy, who are taking other medications, elderly, during pregnancy and breastfeeding.

• It should not be used in children less than 9 years.